Nymirum

Base4 Biotechnology Inc, located in Ann Arbor, MI, is a cutting-edge biotech company focused on developing RNA-targeted therapeutics through innovative small molecule modulation. Their revolutionary structure-based discovery platform enables them to tackle complex diseases in areas such as neurology, oncology, and rare diseases.

By exploiting RNA structural dynamics and utilizing their proprietary DART Platform, Base4 is at the forefront of redefining RNA-targeted therapies, offering new hope for patients with previously untreatable conditions. Their strategic partnerships and commitment to discovery-driven research position them as a leader in the field of RNA drug development.

Generated from the website